Matei Mervat, Matei Sergiu-Ciprian, Petrașcu Flavia-Medana, Golu Ioana, Balaş Melania, Amzăr Daniela, Ungureanu Ana-Maria, Natarâş Bianca Roxana, Vlad Mihaela Maria
Department of Doctoral Studies, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Department of Endocrinology, Emergency County Hospital Timișoara, 300723 Timișoara, Romania.
Medicina (Kaunas). 2025 Jul 14;61(7):1270. doi: 10.3390/medicina61071270.
: The prevalence of thyroid nodules and type 2 diabetes mellitus (T2D) has increased. This study firstly aims to assess the prevalence of T2DM among thyroid nodules patients who underwent total thyroidectomy in the Western Romanian population. By focusing on the biochemical and hormonal parameters, it also aims to provide insights into possible connections between T2D and different types (benignant or malignant) of thyroid nodules. : A total of 926 patients who underwent total thyroidectomy were analysed, comprising 99 (10.7%) T2D patients and 827 (89.3%) non-diabetic patients (non-T2D). : This study's results revealed an increased prevalence of T2D among thyroid nodules patients. Among these patients, higher values of FT4 and inflammatory markers and a higher prevalence of malignant nodules (55%, = 0.001) were noted. : Our study revealed an increased prevalence of T2D among thyroid nodules patients. The biochemical profile of thyroid nodules in T2D patients presents aspects, like elevated FT4 and inflammatory markers, which should be considered in their clinical management. Furthermore, a T2D patient seems to be more likely to develop thyroid malignancies. Thyroid screening strategies in diabetic patients should be considered.
甲状腺结节和2型糖尿病(T2D)的患病率呈上升趋势。本研究首先旨在评估罗马尼亚西部人群中接受全甲状腺切除术的甲状腺结节患者中T2DM的患病率。通过关注生化和激素参数,本研究还旨在深入了解T2D与不同类型(良性或恶性)甲状腺结节之间可能存在的联系。
共分析了926例接受全甲状腺切除术的患者,其中包括99例(10.7%)T2D患者和827例(89.3%)非糖尿病患者(非T2D)。
本研究结果显示,甲状腺结节患者中T2D的患病率有所上升。在这些患者中,FT4和炎症标志物的值较高,恶性结节的患病率也较高(55%,P = 0.001)。
我们的研究显示,甲状腺结节患者中T2D的患病率有所上升。T2D患者甲状腺结节的生化特征呈现出FT4和炎症标志物升高的情况,在其临床管理中应予以考虑。此外,T2D患者似乎更易发生甲状腺恶性肿瘤。应考虑对糖尿病患者进行甲状腺筛查策略。